Biosimulation company Certara said on Thursday that the international registry of healthcare workers will collect information on risk factors for developing COVID-19 as well as using preventative therapies in protecting the healthcare workers during today's global health crisis and for future outbreaks, under The International Registry of Healthcare Workers Exposed to COVID-19 (UNITY Global).
Under UNITY Global, Certara will enable prevention policies based on real-world data collected from 10,000 healthcare workers in low- and middle- income countries. The initiative was funded by the COVID-19 Therapeutics Accelerator. The primary objective is to assess the association between the use of preventive treatments and the occurrence of SARS-CoV-2 infection in healthcare workers.
The company stated the registry first launched in Pakistan on 3 August 2020 and will enroll 10,000 healthcare workers. Additional countries preparing for launch of the registry include South Africa, Nigeria, Kenya, Uganda, Senegal, Zambia and Zimbabwe. The registry collects information on a weekly basis from enrollees across a 12-week period. The registry will record SARS-CoV-2 antibody test results.
Essa Pharma sets ex-dividend date and due bill trading for USD80m capital return
BioDlink's bevacizumab injection secures Colombia and Pakistan marketing authorisation
GSK to receive USD370m and future royalties in CureVac/BioNTech settlement
Ridgetech reports net income of USD10.20m in fiscal year 2025
Genomma Lab Internacional announces Q2 2025 results
Sanofi finalizes acquisition of Blueprint Medicines to expand rare disease and immunology portfolio
CVS Health declares quarterly dividend USD0.665 per share
Lilly declares dividend of USD1.50 for Q3
Bavarian Nordic sells US Priority Review Voucher for USD160m
Bavarian Nordic sells US Priority Review Voucher for USD160m
FDA grants priority review to Innoviva's zoliflodacin for treatment of gonorrhea